March 30, 2009 – Analysis of Boston Scientific’s SYNTAX trial found that while the overall cost effectiveness of ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
March 24, 2009 - Abbott said today it initiated the next phase of the ABSORB clinical trial to evaluate the ...
March 19, 2009 - The FDA has approved an investigational device exemption (IDE) for a multicenter clinical trial ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 18, 2009 - Flexible Stenting Solutions Inc. (FSS) this week submitted an investigational device exemption ...
March 17, 2009 – Twelve-month data from the ATLANTA Trial shows that the CATANIA Coronary Stent System with ...
March 16, 2009 - Cordis Corp. said today it plans to launch a global, head-to-head, randomized clinical trial ...
March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial ...
March 13, 2009 -Medical device pioneer Stentys said today it extended its self-expanding and disconnectable ...
March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during ...
March 10, 2009 - Carotid artery stenting (CAS) has demonstrated outcomes consistent with the American Heart ...
March 5, 2009 - In the first six-year follow-up of a pivotal study of any drug-eluting stent, the clinical ...
March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first ...
March 3, 2009 - Boston Scientific Corp. today said it launched its TAXUS Liberté Paclitaxel-Eluting Coronary Stent ...
February 19, 2009 - C. R. Bard Inc. this week said it received pre-market approval (PMA) from the FDA to market ...
February 19, 2009 - The New England Journal of Medicine this week published the results from the SYNTAX trial, in ...